Skip Navigation
Print This Page
Share this page: More

David S. Cooper, M.D.


Research interests

Hyperthyroidism, thyroid cancer

Recent publications 

•Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76-131.

•Duntas LH, Cooper DS. Review on the occasion of a decade of recombinant human TSH: prospects and novel uses.  Thyroid. 2008;18:509-16.

•Haugen BR, Cooper DS, Emerson CH, Luster M, Maciel RM, Biscolla RP, Mazzaferri EL, Medeiros-Neto G, Reiners C, Robbins RJ, Robinson BG, Schlumberger M, Yamashita S, Pacini F.  Expanding indications for recombinant human TSH in thyroid cancer.  Thyroid. 2008;18:687-94.

•Cooper DS, Rivkees SA.  Putting propylthiouracil in perspective.  J Clin Endocrinol Metab. 2009;94:1881-2

•Kharlip J, Cooper DS.  Recent developments in hyperthyroidism.  Lancet. 2009 373(9679):1930-2.

•Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN.  The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.  Thyroid. 2009;19:673-4.

•Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, Robbins J, Skarulis MC, Steward DL, Maxon HR, Sherman SI.

•Recurrence after treatment of micropapillary thyroid cancer.  Thyroid. 2009;19:1043-8.

•Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.  Thyroid. 2009;19:1167-214.

•Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, Randolph GW, Stack BC Jr, Steward DL, Terris DJ, Thompson GB, Tufano RP, Tuttle RM, Udelsman R. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.  Thyroid. 2009;19:1153-8.

•Biondi B, Cooper DS.  Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.  Thyroid. 2010;20:135-46.

•Emiliano AB, Governale L, Parks M, Cooper DS.  Shifts in Propylthiouracil and Methimazole Prescribing Practices: Antithyroid Drug Use in the United States from 1991 to 2008. 

•J Clin Endocrinol Metab. 2010;95:2227-33.


Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer